Dawn Cohen is a Director of Attribute Sciences in Process Development at Amgen. Dawn leads a team that is responsible for global method transfer and validation, analytical leadership of commercial portfolio assets and the application of analytical subject matter expertise to advance the pipeline and ensure sustained supply. Prior to her current role Dawn formed a new Attribute Sciences team at Amgen's commercial manufacturing site in Dun Laoghaire, Ireland. Dawn has experience serving as Attribute Sciences team lead on multiple programs of varying modality across different stages of development and has also worked at Amgen sites in Cambridge, Massachusetts and Thousand Oaks, California. Dawn holds a PhD in Chemistry from the University of Washington in Seattle and a Bachelor of Science in Chemistry from Drexel University in Pennsylvania.